Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 1
1979 1
1980 2
1981 1
1982 2
1983 2
1984 4
1985 1
1986 1
1987 1
1988 2
1989 2
1990 2
1991 3
1992 2
1994 1
1995 1
1996 2
1997 3
1999 1
2000 2
2001 5
2002 7
2003 6
2004 6
2005 4
2006 6
2007 13
2008 6
2009 15
2010 10
2011 12
2012 18
2013 11
2014 9
2015 8
2016 10
2017 12
2018 8
2019 8
2020 10
2021 7
2022 11
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Topical benzoyl peroxide for acne.
Yang Z, Zhang Y, Lazic Mosler E, Hu J, Li H, Zhang Y, Liu J, Zhang Q. Yang Z, et al. Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD011154. doi: 10.1002/14651858.CD011154.pub2. Cochrane Database Syst Rev. 2020. PMID: 32175593 Free PMC article.
BACKGROUND: Acne is a common, economically burdensome condition that can cause psychological harm and, potentially, scarring. Topical benzoyl peroxide (BPO) is a widely used acne treatment; however, its efficacy and safety have not been clearly evaluated. ...
BACKGROUND: Acne is a common, economically burdensome condition that can cause psychological harm and, potentially, scarring. Topical ben
Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
Aschoff R, Möller S, Haase R, Kuske M. Aschoff R, et al. J Drugs Dermatol. 2021 Mar 1;20(3):295-301. doi: 10.36849/JDD.2021.5641. J Drugs Dermatol. 2021. PMID: 33683070 Clinical Trial.
This evaluator-blinded pilot study compared the efficacy and tolerability of two marketed topical combination acne gels, clindamycin 1%-tretinoin 0.025% (CT) and benzoyl peroxide 2.5%-adapalene 0.1% (BA) in 20 patients with mild to moderate acne vulgaris. ...
This evaluator-blinded pilot study compared the efficacy and tolerability of two marketed topical combination acne gels, clindamycin 1%-tret …
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl peroxide (BPO) 3.1%/adapalene 0.15% (IDP-126) gel for the treatment of acne. ...
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl
Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies.
Del Rosso J, Sugarman J, Green L, Lain T, Levy-Hacham O, Mizrahi R, Gold LS. Del Rosso J, et al. J Am Acad Dermatol. 2023 Oct;89(4):719-727. doi: 10.1016/j.jaad.2023.05.093. Epub 2023 Jun 24. J Am Acad Dermatol. 2023. PMID: 37356627 Free article. Clinical Trial.
BACKGROUND: Benzoyl peroxide and tretinoin are commonly prescribed acne treatments. ...
BACKGROUND: Benzoyl peroxide and tretinoin are commonly prescribed acne treatments. ...
A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.
Mavranezouli I, Daly CH, Welton NJ, Deshpande S, Berg L, Bromham N, Arnold S, Phillippo DM, Wilcock J, Xu J, Ravenscroft JC, Wood D, Rafiq M, Fou L, Dworzynski K, Healy E. Mavranezouli I, et al. Br J Dermatol. 2022 Nov;187(5):639-649. doi: 10.1111/bjd.21739. Epub 2022 Aug 22. Br J Dermatol. 2022. PMID: 35789996 Free PMC article. Review.
For mild-to-moderate acne, the most effective options for each treatment type were as follows: topical pharmacological - combined retinoid with benzoyl peroxide (BPO) [mean difference 26.16%, 95% credible interval (CrI) 16.75-35.36%]; physical - chemical peels, e.g. …
For mild-to-moderate acne, the most effective options for each treatment type were as follows: topical pharmacological - combined retinoid w …
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Aarts P, Reeves JL, Ardon CB, van der Zee HH, Prens EP. Aarts P, et al. Dermatology. 2023;239(4):670-674. doi: 10.1159/000530758. Epub 2023 Apr 20. Dermatology. 2023. PMID: 37080176 Free PMC article. Clinical Trial.
METHODS: This is a randomized, controlled, assessor-blinded, intra-patient pilot trial to compare the clinical efficacy of clindamycin-benzoyl peroxide gel with clindamycin lotion in patients with mild to moderate HS. ...A significant decrease was observed in the IH …
METHODS: This is a randomized, controlled, assessor-blinded, intra-patient pilot trial to compare the clinical efficacy of clindamycin-be
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
Draelos ZD, Tanghetti EA, Kircik LH, Bhatia N, Zeichner JA, Sugarman JL, Stein Gold L. Draelos ZD, et al. J Dermatolog Treat. 2023 Dec;34(1):2220446. doi: 10.1080/09546634.2023.2220446. J Dermatolog Treat. 2023. PMID: 37341243 Free article. Clinical Trial.
Herein are the dermal sensitization, irritation, safety, and tolerability results from phase 1 and 2 studies of fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide (BPO) 3.1%/adapalene 0.15% (IDP-126) polymeric mesh gel. ...
Herein are the dermal sensitization, irritation, safety, and tolerability results from phase 1 and 2 studies of fixed-dose clindamycin phosp …
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H, Peinemann F. Liu H, et al. Cochrane Database Syst Rev. 2020 May 1;5(5):CD011368. doi: 10.1002/14651858.CD011368.pub2. Cochrane Database Syst Rev. 2020. PMID: 32356369 Free PMC article.
We are uncertain whether there is a difference in withdrawals between salicylic acid and benzoyl peroxide (1 study, 41 participants; very low-quality evidence). ...Neither group had withdrawals (2 studies, 84 participants; low-quality evidence). AUTHORS' CONCLUSIONS …
We are uncertain whether there is a difference in withdrawals between salicylic acid and benzoyl peroxide (1 study, 41 partici …
Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis.
Tanizaki H, Hayashi N, Abe M. Tanizaki H, et al. J Dermatol. 2023 Dec;50(12):1513-1522. doi: 10.1111/1346-8138.16942. Epub 2023 Sep 4. J Dermatol. 2023. PMID: 37665181 Clinical Trial.
Compared with the control group, the success rates were significantly higher in the adapalene/benzoyl peroxide and benzoyl peroxide groups (P = 0.0006 for both). ...Adverse drug reactions were noted in three patients in the adapalene/benzoyl
Compared with the control group, the success rates were significantly higher in the adapalene/benzoyl peroxide and benzoyl
A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide.
Khammari A, Demessant-Flavigny A, Kerob D, Seité S, Dréno B. Khammari A, et al. J Drugs Dermatol. 2023 Dec 1;22(12):1172-1177. doi: 10.36849/JDD.7449. J Drugs Dermatol. 2023. PMID: 38051857 Clinical Trial.
BACKGROUND: A dermocosmetic (DC) containing salicylic acid, niacinamide, and thermal spring water has been developed for the management of mild to moderate acne. AIM: To assess the efficacy of DC as an adjunct to benzoyl peroxide (BPO) every other day compared with …
BACKGROUND: A dermocosmetic (DC) containing salicylic acid, niacinamide, and thermal spring water has been developed for the management of m …
245 results